Carol Reynolds Selected Research

Carol Reynolds Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 01/2002
18	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2002
5	Neoplasm Metastasis (Metastasis) 06/2011 - 11/2005
4	Leukemia 12/2022 - 03/2003
4	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2022 - 08/2004
4	Hyperplasia 10/2011 - 03/2008
3	Carcinoma (Carcinomatosis) 10/2011 - 09/2009
2	Injection Site Reaction 12/2022 - 11/2017
2	Lymphoma (Lymphomas) 01/2022 - 01/2017
2	Viremia 01/2022 - 05/2010
2	Hematologic Neoplasms (Hematological Malignancy) 10/2016 - 05/2010
2	Carcinoma in Situ 10/2011 - 03/2011
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Triple Negative Breast Neoplasms 10/2014
1	Amyloidosis 02/2013
1	Ductal Carcinoma 08/2011
1	Gynecomastia 08/2011
1	Edema (Dropsy) 12/2010
1	Hemangiosarcoma (Angiosarcoma) 02/2008
1	Tetanus 07/2006
1	Bronchiolitis Obliterans Syndrome 07/2006
1	Hot Flashes 12/2005
1	Microsatellite Instability 11/2003
1	Residual Neoplasm 03/2003
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2003

Drug/Important Bio-Agent (IBA)

4	Hormones (Hormone)IBA 01/2022 - 01/2011
4	Tamoxifen FDA LinkGeneric 10/2014 - 11/2005
4	Proteins (Proteins, Gene)FDA Link 02/2013 - 08/2005
4	Estrogen ReceptorsIBA 06/2012 - 04/2008
3	Biological ProductsIBA 01/2022 - 02/2012
3	SteroidsIBA 01/2017 - 08/2004
3	Biomarkers (Surrogate Marker)IBA 06/2012 - 03/2008
3	DNA (Deoxyribonucleic Acid)IBA 05/2010 - 01/2002
3	EnzymesIBA 05/2010 - 01/2007
2	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 11/2017
2	VaccinesIBA 12/2022 - 11/2017
2	Monoclonal AntibodiesIBA 01/2017 - 03/2003
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2010 - 03/2003
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2007 - 12/2005
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2022
1	Methotrexate (Mexate)FDA LinkGeneric 12/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	pembrolizumabIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Brentuximab VedotinIBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2014
1	Immunoglobulins (Immunoglobulin)IBA 02/2013
1	Amyloid (Amyloid Fibrils)IBA 02/2013
1	Protein Isoforms (Isoforms)IBA 06/2012
1	Insulin ReceptorIBA 06/2012
1	Estrogen Receptor alphaIBA 02/2012
1	AntibodiesIBA 02/2012
1	Keratin-7 (Cytokeratin 7)IBA 10/2011
1	Octreotide (Sandostatin)FDA LinkGeneric 06/2011
1	Estrogens (Estrogen)FDA Link 01/2011
1	Aromatase (CYP19)IBA 01/2011
1	ORALIT (ORS)IBA 12/2010
1	Dihydrotachysterol (AT 10)IBA 06/2010
1	Interferon-gamma (Interferon, gamma)IBA 05/2010
1	ImmunosorbentsIBA 05/2010
1	Phosphotransferases (Kinase)IBA 09/2009
1	Protein Kinases (Protein Kinase)IBA 09/2009
1	SNF1-related protein kinasesIBA 09/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2008
1	Rituximab (Mabthera)FDA Link 07/2006
1	AntigensIBA 07/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2006
1	4-hydroxy-N-desmethyltamoxifenIBA 12/2005
1	Cytochrome P-450 CYP3AIBA 12/2005
1	ParaffinIBA 12/2005
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2005
1	denileukin diftitox (Ontak)FDA Link 08/2004
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2003
1	RicinIBA 03/2003
1	Immunotoxins (Immunotoxin)IBA 03/2003
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 03/2003

Therapy/Procedure

11	Therapeutics 01/2022 - 02/2002
4	Lymph Node Excision (Lymph Node Dissection) 10/2010 - 10/2005
3	Mastectomy (Mammectomy) 10/2011 - 10/2002
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2005
2	Transplantation 10/2016 - 05/2010
2	Prophylactic Mastectomy 10/2011 - 01/2003
1	Immunotherapy 01/2022
1	Stem Cell Transplantation 01/2022
1	Cell Transplantation 01/2020
1	Lipectomy (Liposuction) 08/2011
1	Adjuvant Chemotherapy 01/2011
1	Chemoprevention 03/2008
1	Segmental Mastectomy (Lumpectomy) 02/2008
1	Hematopoietic Stem Cell Transplantation 08/2004
1	Lasers (Laser) 11/2003
1	Adjuvant Radiotherapy 10/2002